| GIVOSIRAN SODIUM | Alnylam Pharms INC | ||
| EQ 189MG BASE/ML (EQ 189MG BASE/ML) ; Solution |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| GIVLAARI is an aminolevulinate synthase 1-directed small interfering RNA indicated for the treatment of adults with acute hepatic porphyria (AHP). | |||
|
Yes
| |||
| GIVLAARI | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||
| ************ *** ******* *** ********** ********** ** * ****** **** | ************ ********** *********** *′-******** *********** *** *** ** **** ********** | *********** ************ | *********** ************ | *********** ************ | ************ ********** *********** *′-******** *********** *** *** ** **** ********** | *************** ** *** ************ ****** | ************ ********** ** ******** ****** *** **************** | ************ ********** ** ******** ****** *** **************** | ************ *** ******* *** ********** ********** ** *** ***** **** | ************ *** ******* *** ********** ********** ** *** ***** **** | ************ *** ******* *** ********** ********** ** *** ***** **** | ************ *** ******* *** ********** ********** ** *** ***** **** | ************ *** ******* *** ********** ********** ** *** ***** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|